Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS To Cover Established Cardiovascular Tests Under Screening Benefit

This article was originally published in The Gray Sheet

Executive Summary

The Centers for Medicare & Medicaid Services is leaving the door open to coverage of newer cardiovascular tests under the MMA preventive screening benefit, despite an initial decision to limit the policy to three established tests

You may also be interested in...



NEJM Study Deems CRP Significant, Compared With Other Cardiac Markers

A recent New England Journal of Medicine study identifying C-reactive protein as a significant marker of coronary heart disease risk may prove to be a boon for CRP diagnostic manufacturers

NEJM Study Deems CRP Significant, Compared With Other Cardiac Markers

A recent New England Journal of Medicine study identifying C-reactive protein as a significant marker of coronary heart disease risk may prove to be a boon for CRP diagnostic manufacturers

CMS To Add Diabetes, Cardiovascular Screening Tests Through NCD Process

CMS will continue to use the national coverage determination process for adding diabetes and cardiovascular screening tests, despite AdvaMed's criticism that the process is overly burdensome

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel